Establishment and characterization of unique human gallbladder cancer cell lines. 2004

Mila Ghosh, and Naoto Koike, and Go Yanagimoto, and Shin-Ichi Tsunoda, and Sunil Kaul, and Takashi Hirano, and Fabian Emura, and Hironobu Kashiwagi, and Toru Kawamoto, and Nobuhiro Ohkohchi, and Kaoru Saijo, and Tadao Ohno, and Masanao Miwa, and Takeshi Todoroki
Department of Surgery, Institute of Clinical Medicine, University of Tsukuba, Tsukuba-shi, Japan.

Gallbladder cancer has a dismal prognosis. Understanding the disease at the biological, genetic, molecular, cellular, and clinical level is essential for effective diagnostics and therapeutics. However, the currently established gallbladder cell lines are insufficient for better understanding and further research. The aim of our present study was to establish and characterize human gallbladder cancer cell lines. We established 5 cell lines from resected specimens of gallbladder cancers. These cell lines revealed typical tumor histopathological characteristics. We examined growth characteristics and the colony-forming ability of established cell lines in terms of their cell cycle parameters, expression of tumor markers (carcinoembryonic antigen; CEA, carbohydrated antigen 19-9; CA19-9, MUC-1 and c-kit) and the oncogene c-erbB2 by flow cytometer. Comparative genomic hybridization (CGH) analysis with specific gene probes was performed to detect changes in the gene copy numbers. Human origin of cell lines was confirmed by chromosomal analysis. Cells maintained differentiation characteristics of the original tumors. The doubling time of different cell lines varied from 30 to 96 h. All 5 cell lines formed colonies in the colony forming assays and expressed CEA, CA19-9, MUC-1 and the oncogene c-erbB2 and showed chromosomal aneuploidy. CGH analysis demonstrated gain of chromosomal region bearing SRC, RAB1, and PAP in all cell lines and hTERT in 4 cell lines. These newly established cell lines might serve as a useful model for studying the molecular pathogenesis of gallbladder cancer. Furthermore, they may serve as a model for testing new therapeutics against gallbladder cancer. These chromosomal aberrations and imbalances provide a starting point for molecular analyses of genomic regions and genes in gallbladder carcinogenesis.

UI MeSH Term Description Entries
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D009693 Nucleic Acid Hybridization Widely used technique which exploits the ability of complementary sequences in single-stranded DNAs or RNAs to pair with each other to form a double helix. Hybridization can take place between two complimentary DNA sequences, between a single-stranded DNA and a complementary RNA, or between two RNA sequences. The technique is used to detect and isolate specific sequences, measure homology, or define other characteristics of one or both strands. (Kendrew, Encyclopedia of Molecular Biology, 1994, p503) Genomic Hybridization,Acid Hybridization, Nucleic,Acid Hybridizations, Nucleic,Genomic Hybridizations,Hybridization, Genomic,Hybridization, Nucleic Acid,Hybridizations, Genomic,Hybridizations, Nucleic Acid,Nucleic Acid Hybridizations
D002272 Carcinoembryonic Antigen A glycoprotein that is secreted into the luminal surface of the epithelia in the gastrointestinal tract. It is found in the feces and pancreaticobiliary secretions and is used to monitor the response to colon cancer treatment. Antigens, CD66e,CD66e Antigen,Antigen, CD66e,Antigen, Carcinoembryonic,CD66e Antigens
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D003114 Colony-Forming Units Assay A cytologic technique for measuring the functional capacity of stem cells by assaying their activity. Clonogenic Cell Assay,Stem Cell Assay,Clonogenic Cell Assays,Colony Forming Units Assays,Colony-Forming Units Assays,Stem Cell Assays,Assay, Clonogenic Cell,Assay, Colony-Forming Units,Assay, Stem Cell,Assays, Clonogenic Cell,Assays, Colony-Forming Units,Assays, Stem Cell,Colony Forming Units Assay
D005706 Gallbladder Neoplasms Tumors or cancer of the gallbladder. Cancer of Gallbladder,Gallbladder Cancer,Cancer of the Gallbladder,Gall Bladder Cancer,Neoplasms, Gallbladder,Bladder Cancer, Gall,Bladder Cancers, Gall,Cancer, Gall Bladder,Cancer, Gallbladder,Cancers, Gall Bladder,Cancers, Gallbladder,Gall Bladder Cancers,Gallbladder Cancers,Gallbladder Neoplasm,Neoplasm, Gallbladder
D005784 Gene Amplification A selective increase in the number of copies of a gene coding for a specific protein without a proportional increase in other genes. It occurs naturally via the excision of a copy of the repeating sequence from the chromosome and its extrachromosomal replication in a plasmid, or via the production of an RNA transcript of the entire repeating sequence of ribosomal RNA followed by the reverse transcription of the molecule to produce an additional copy of the original DNA sequence. Laboratory techniques have been introduced for inducing disproportional replication by unequal crossing over, uptake of DNA from lysed cells, or generation of extrachromosomal sequences from rolling circle replication. Amplification, Gene

Related Publications

Mila Ghosh, and Naoto Koike, and Go Yanagimoto, and Shin-Ichi Tsunoda, and Sunil Kaul, and Takashi Hirano, and Fabian Emura, and Hironobu Kashiwagi, and Toru Kawamoto, and Nobuhiro Ohkohchi, and Kaoru Saijo, and Tadao Ohno, and Masanao Miwa, and Takeshi Todoroki
January 1991, Annals of the New York Academy of Sciences,
Mila Ghosh, and Naoto Koike, and Go Yanagimoto, and Shin-Ichi Tsunoda, and Sunil Kaul, and Takashi Hirano, and Fabian Emura, and Hironobu Kashiwagi, and Toru Kawamoto, and Nobuhiro Ohkohchi, and Kaoru Saijo, and Tadao Ohno, and Masanao Miwa, and Takeshi Todoroki
December 1984, Cancer research,
Mila Ghosh, and Naoto Koike, and Go Yanagimoto, and Shin-Ichi Tsunoda, and Sunil Kaul, and Takashi Hirano, and Fabian Emura, and Hironobu Kashiwagi, and Toru Kawamoto, and Nobuhiro Ohkohchi, and Kaoru Saijo, and Tadao Ohno, and Masanao Miwa, and Takeshi Todoroki
April 2020, Scientific reports,
Mila Ghosh, and Naoto Koike, and Go Yanagimoto, and Shin-Ichi Tsunoda, and Sunil Kaul, and Takashi Hirano, and Fabian Emura, and Hironobu Kashiwagi, and Toru Kawamoto, and Nobuhiro Ohkohchi, and Kaoru Saijo, and Tadao Ohno, and Masanao Miwa, and Takeshi Todoroki
March 1996, Human cell,
Mila Ghosh, and Naoto Koike, and Go Yanagimoto, and Shin-Ichi Tsunoda, and Sunil Kaul, and Takashi Hirano, and Fabian Emura, and Hironobu Kashiwagi, and Toru Kawamoto, and Nobuhiro Ohkohchi, and Kaoru Saijo, and Tadao Ohno, and Masanao Miwa, and Takeshi Todoroki
June 1988, Human cell,
Mila Ghosh, and Naoto Koike, and Go Yanagimoto, and Shin-Ichi Tsunoda, and Sunil Kaul, and Takashi Hirano, and Fabian Emura, and Hironobu Kashiwagi, and Toru Kawamoto, and Nobuhiro Ohkohchi, and Kaoru Saijo, and Tadao Ohno, and Masanao Miwa, and Takeshi Todoroki
January 2012, Molecular medicine reports,
Mila Ghosh, and Naoto Koike, and Go Yanagimoto, and Shin-Ichi Tsunoda, and Sunil Kaul, and Takashi Hirano, and Fabian Emura, and Hironobu Kashiwagi, and Toru Kawamoto, and Nobuhiro Ohkohchi, and Kaoru Saijo, and Tadao Ohno, and Masanao Miwa, and Takeshi Todoroki
September 1976, Cancer research,
Mila Ghosh, and Naoto Koike, and Go Yanagimoto, and Shin-Ichi Tsunoda, and Sunil Kaul, and Takashi Hirano, and Fabian Emura, and Hironobu Kashiwagi, and Toru Kawamoto, and Nobuhiro Ohkohchi, and Kaoru Saijo, and Tadao Ohno, and Masanao Miwa, and Takeshi Todoroki
December 1978, National Cancer Institute monograph,
Mila Ghosh, and Naoto Koike, and Go Yanagimoto, and Shin-Ichi Tsunoda, and Sunil Kaul, and Takashi Hirano, and Fabian Emura, and Hironobu Kashiwagi, and Toru Kawamoto, and Nobuhiro Ohkohchi, and Kaoru Saijo, and Tadao Ohno, and Masanao Miwa, and Takeshi Todoroki
September 1990, Cancer research,
Mila Ghosh, and Naoto Koike, and Go Yanagimoto, and Shin-Ichi Tsunoda, and Sunil Kaul, and Takashi Hirano, and Fabian Emura, and Hironobu Kashiwagi, and Toru Kawamoto, and Nobuhiro Ohkohchi, and Kaoru Saijo, and Tadao Ohno, and Masanao Miwa, and Takeshi Todoroki
April 1992, Cancer,
Copied contents to your clipboard!